Stockscreener 앱 받기
2.02
7.34%
-0.16
시장 영업 전:
2.05
0.03
+1.49%
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Shareholders Approve Equity Plan and Capital Measures - TipRanks
Investors in bioAffinity (NASDAQ: BIAF) register 497,483 shares for resale - Stock Titan
bioAffinity Technologies (BIAF) wins approval for major equity plan, offerings and reverse split - Stock Titan
BioAffinity stock surges 113.8% in 3 months: What's driving the rally? - MSN
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment - BioSpace
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
BIAF stock gains as CyPath sales surge 146% in Q1 - MSN
bioAffinity Technologies prices $4.8 million public offering; shares down over 30% - MSN
bioAffinity Technologies Working With U.S. Army on CyPath Lung Study - Medical Product Outsourcing
BioAffinity (BIAF) Stock in Focus Today (Volatility Increases) 2026-04-20Trading Community - Cổng thông tin điện tử tỉnh Lào Cai
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
BioAffinity (BIAF) Stock Slides (Breakdown Watch) 2026-04-16Shared Momentum Picks - Cổng thông tin điện tử Tỉnh Sơn La
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - The Globe and Mail
New Case Study Shows bioAffinity Technologies CyPath Lung Diagnostic Helps Avoid Unnecessary Lung Biopsy - National Today
CyPath® Lung Diagnostic Helps Defer Unnecessary Biopsy - National Today
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy - BioSpace
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, P - PharmiWeb.com
bioAffinity Highlights CyPath Lung Case Avoiding Unnecessary Biopsy - TipRanks
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows biopsy deferred - Stock Titan
UGRO, TURB, ANNA, EEIQ, BIAF: These five stocks outpaced big tech with massive March returns - MSN
Institution Moves: Can bioAffinity Technologies Inc lead its sector in growth2026 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Investment Review: Is bioAffinity Technologies Inc Equity Warrant stock overvalued or fairly priced2026 Buyback Activity & Technical Pattern Based Buy Signals - baoquankhu1.vn
BIAF PE Ratio & Valuation, Is BIAF Overvalued - Intellectia AI
Wall Street Recap: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil pricesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
Jobs Data: What hedge funds are buying bioAffinity Technologies Inc Equity WarrantWeekly Trading Summary & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
What is the volatility of BioAffinity (BIAF) Stock | Price at $3.54, Up 6.66%Growth Investing - Cổng thông tin điện tử Tỉnh Sơn La
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early - PharmiWeb.com
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 - BioSpace
bioAffinity Showcases CyPath Lung Test at Cleveland Clinic - TipRanks
CyPath Lung spotlight for bioAffinity Technologies (Nasdaq: BIAF) - Stock Titan
Risk Analysis: What are the future prospects of bioAffinity Technologies Inc Equity Warrant2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Is BioAffinity (BIAF) Stock Showing Strength | Price at $3.88, Down 1.02%Hot Market Picks - Cổng thông tin điện tử Tỉnh Sơn La
BIAFW Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - stocktwits.com
BIAF Should I Buy - Intellectia AI
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
BIAF Stock Price $3.76 | bioAffinity Technologies, Inc. Live Quote - Meyka
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com South Africa
1.63%
0.34%
자본화:
|
볼륨(24시간):